1. Home
  2. Pharma & Healthcare
  3. Global Contract Pharmaceutical Manufacturing Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Contract Pharmaceutical Manufacturing Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 149 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Contract Pharmaceutical Manufacturing market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Contract Pharmaceutical Manufacturing market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Contract Pharmaceutical Manufacturing in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
API
FDF

Market Snapshot, By Application
Specialty/Midsize
Generics
Big Pharma
Other

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
Vetter
Sopharma
Recipharm
Piramal Healthcare
Nipro Corp
NextPharma
Lonza
Jubilant
Fareva Holding
Famar
DPx
DPT Laboratories
Dishman
Catalent
Boehringer Ingelheim
Aesica
Aenova
AbbVie

The study objectives of this report are:
To study and analyze the global Contract Pharmaceutical Manufacturing market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Contract Pharmaceutical Manufacturing market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Contract Pharmaceutical Manufacturing manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Contract Pharmaceutical Manufacturing market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Contract Pharmaceutical Manufacturing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Contract Pharmaceutical Manufacturing are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Contract Pharmaceutical Manufacturing Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Contract Pharmaceutical Manufacturing Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Contract Pharmaceutical Manufacturing

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Contract Pharmaceutical Manufacturing Sales Channel and Distributors Analysis
3.3.1 Contract Pharmaceutical Manufacturing Sales Channel
3.3.2 Contract Pharmaceutical Manufacturing Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Contract Pharmaceutical Manufacturing Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Contract Pharmaceutical Manufacturing Type Introduction
4.1.1 API
4.1.2 FDF
4.2 Global Contract Pharmaceutical Manufacturing Sales by Type 2016-2021
4.3 Global Contract Pharmaceutical Manufacturing Revenue by Type 2016-2021
4.4 Global Contract Pharmaceutical Manufacturing Price by Type 2016-2021

5 Market Segment: by Application
5.1 Contract Pharmaceutical Manufacturing Type Introduction
5.1.1 Specialty/Midsize
5.1.2 Generics
5.1.3 Big Pharma
5.1.3 Other
5.2 Global Contract Pharmaceutical Manufacturing Sales by Application 2016-2021
5.3 Global Contract Pharmaceutical Manufacturing Revenue by Application 2016-2021
5.4 Global Contract Pharmaceutical Manufacturing Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Contract Pharmaceutical Manufacturing Market by Region
6.1.1 Global Contract Pharmaceutical Manufacturing Sales by Regions
6.1.2 Global Contract Pharmaceutical Manufacturing Revenue by Regions
6.2 North America Contract Pharmaceutical Manufacturing Market 2016-2021
6.3 Europe Contract Pharmaceutical Manufacturing Market 2016-2021
6.4 Asia Pacific Contract Pharmaceutical Manufacturing Market 2016-2021
6.5 South America Contract Pharmaceutical Manufacturing Market 2016-2021
6.6 Middle East and Africa Contract Pharmaceutical Manufacturing Market 2016-2021

7 North America
7.1 North America Contract Pharmaceutical Manufacturing Market by Country 2016-2021
7.1.1 North America Contract Pharmaceutical Manufacturing Sales by Country
7.1.2 North America Contract Pharmaceutical Manufacturing Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Contract Pharmaceutical Manufacturing Market by Country 2016-2021
8.1.1 Europe Contract Pharmaceutical Manufacturing Sales by Country
8.1.2 Europe Contract Pharmaceutical Manufacturing Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Contract Pharmaceutical Manufacturing Market by Country 2016-2021
9.1.1 Asia Pacific Contract Pharmaceutical Manufacturing Sales by Country
9.1.2 Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Contract Pharmaceutical Manufacturing Market by Country 2016-2021
10.1.1 South America Contract Pharmaceutical Manufacturing Sales by Country
10.1.2 South America Contract Pharmaceutical Manufacturing Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Contract Pharmaceutical Manufacturing Market by Country 2016-2021
11.1.1 Middle East and Africa Contract Pharmaceutical Manufacturing Sales by Country
11.1.2 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Vetter
12.1.1 Vetter Company Information
12.1.2 Vetter Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
12.1.3 Vetter Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Vetter Key Development
12.2 Sopharma
12.2.1 Sopharma Company Information
12.2.2 Sopharma Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
12.2.3 Sopharma Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Sopharma Key Development
12.3 Recipharm
12.3.1 Recipharm Company Information
12.3.2 Recipharm Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
12.3.3 Recipharm Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Recipharm Key Development
12.4 Piramal Healthcare
12.4.1 Piramal Healthcare Company Information
12.4.2 Piramal Healthcare Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
12.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Piramal Healthcare Key Development
12.5 Nipro Corp
12.5.1 Nipro Corp Company Information
12.5.2 Nipro Corp Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
12.5.3 Nipro Corp Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Nipro Corp Key Development
12.6 NextPharma
12.6.1 NextPharma Company Information
12.6.2 NextPharma Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
12.6.3 NextPharma Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 NextPharma Key Development
12.7 Lonza
12.7.1 Lonza Company Information
12.7.2 Lonza Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
12.7.3 Lonza Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 NextPharma Key Development
12.9 Fareva Holding
12.9.1 Fareva Holding Company Information
12.9.2 Fareva Holding Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
12.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Fareva Holding Key Development
12.8 Jubilant
12.8.1 Jubilant Company Information
12.8.2 Jubilant Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
12.8.3 Jubilant Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Jubilant Key Development
12.11 DPx
12.11.1 DPx Company Information
12.11.2 DPx Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
12.11.3 DPx Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 DPx Key Development
12.12 DPT Laboratories
12.12.1 DPT Laboratories Company Information
12.12.2 DPT Laboratories Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
12.12.3 DPT Laboratories Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 DPT Laboratories Key Development
12.13 Dishman
12.13.1 Dishman Company Information
12.13.2 Dishman Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
12.13.3 Dishman Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 Dishman Key Development
12.14 Catalent
12.14.1 Catalent Company Information
12.14.2 Catalent Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
12.14.3 Catalent Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Catalent Key Development
12.15 Boehringer Ingelheim
12.15.1 Boehringer Ingelheim Company Information
12.15.2 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
12.15.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Boehringer Ingelheim Key Development
12.17 Aenova
12.18 AbbVie

13 Global Contract Pharmaceutical Manufacturing Market Forecast by Region by Type and by Application
13.1 Global Contract Pharmaceutical Manufacturing Sales, Revenue Forecast 2022-2027
13.2 Global Contract Pharmaceutical Manufacturing Forecast by Regions
13.2.1 Global Contract Pharmaceutical Manufacturing Sales Forecast by Region 2022-2027
13.2.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Region 2022-2027
13.3 Global Contract Pharmaceutical Manufacturing Forecast by Type
13.3.1 Global Contract Pharmaceutical Manufacturing Sales Forecast by Type 2022-2027
13.3.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Type 2022-2027
13.3.3 Global Contract Pharmaceutical Manufacturing Price Forecast by Type 2022-2027
13.4 Global Contract Pharmaceutical Manufacturing Forecast by Application
13.4.1 Global Contract Pharmaceutical Manufacturing Sales Forecast by Application 2022-2027
13.4.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Application 2022-2027
13.4.3 Global Contract Pharmaceutical Manufacturing Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Contract Pharmaceutical Manufacturing Production Specifications
Table 2: Drivers in Contract Pharmaceutical Manufacturing Market
Table 3: Restraints Contract Pharmaceutical Manufacturing Market
Table 4: Opportunity in Contract Pharmaceutical Manufacturing Market
Table 5: Comparion of Alternative and Contract Pharmaceutical Manufacturing
Table 6: Contract Pharmaceutical Manufacturing Raw Materials Key Suppliers List
Table 7: Contract Pharmaceutical Manufacturing Distributors List
Table 8: Contract Pharmaceutical Manufacturing Major Buyers in Application One
Table 9: Contract Pharmaceutical Manufacturing Major Buyers in Application Two
Table 10: Contract Pharmaceutical Manufacturing Major Buyers in Application Three
Table 11: Global Contract Pharmaceutical Manufacturing Sales (K Units) by Type 2016-2021
Table 12: Global Contract Pharmaceutical Manufacturing Sales Market Share by Type 2016-2021
Table 13: Global Contract Pharmaceutical Manufacturing Revenue (Million USD) by Type 2016-2021
Table 14: Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type 2016-2021
Table 15: Global Contract Pharmaceutical Manufacturing Price by Type 2016-2021
Table 16: Global Contract Pharmaceutical Manufacturing Sales (K Units) by Application 2016-2021
Table 17: Global Contract Pharmaceutical Manufacturing Sales Market Share by Application 2016-2021
Table 18: Global Contract Pharmaceutical Manufacturing Revenue (Million USD) by Application 2016-2021
Table 19: Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application 2016-2021
Table 20: Global Contract Pharmaceutical Manufacturing Price by Application 2016-2021
Table 21: Global Contract Pharmaceutical Manufacturing Sales (K Units) by Region 2016-2021
Table 22: Global Contract Pharmaceutical Manufacturing Sales Market Share by Region 2016-2021
Table 23: Global Contract Pharmaceutical Manufacturing Revenue (Million USD) by Region 2016-2021
Table 24: Global Contract Pharmaceutical Manufacturing Revenue Market Share by Region 2016-2021
Table 25: North America Contract Pharmaceutical Manufacturing Sales (K Units) by Country 2016-2021
Table 26: North America Contract Pharmaceutical Manufacturing Sales Market Share by Country 2016-2021
Table 27: North America Contract Pharmaceutical Manufacturing Revenue (Million USD) by Country 2016-2021
Table 28: North America Contract Pharmaceutical Manufacturing Revenue Market Share by Country 2016-2021)
Table 29: Europe Contract Pharmaceutical Manufacturing Sales (K Units) by Country 2016-2021
Table 30: Europe Contract Pharmaceutical Manufacturing Sales Market Share by Country 2016-2021
Table 31: Europe Contract Pharmaceutical Manufacturing Revenue (Million USD) by Country 2016-2021
Table 32: Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Contract Pharmaceutical Manufacturing Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Contract Pharmaceutical Manufacturing Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Contract Pharmaceutical Manufacturing Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Country 2016-2021)
Table 37: South America Contract Pharmaceutical Manufacturing Sales (K Units) by Country 2016-2021
Table 38: South America Contract Pharmaceutical Manufacturing Sales Market Share by Country 2016-2021
Table 39: South America Contract Pharmaceutical Manufacturing Revenue (Million USD) by Country 2016-2021
Table 40: South America Contract Pharmaceutical Manufacturing Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Contract Pharmaceutical Manufacturing Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Contract Pharmaceutical Manufacturing Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Contract Pharmaceutical Manufacturing Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Country 2016-2021)
Table 45 Vetter Company Information
Table 46 Vetter Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
Table 47 Vetter Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Sopharma Company Information
Table 49 Sopharma Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
Table 50 Sopharma Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Recipharm Company Information
Table 52 Recipharm Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
Table 53 Recipharm Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Piramal Healthcare Company Information
Table 55 Piramal Healthcare Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
Table 56 Piramal Healthcare Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Nipro Corp Company Information
Table 58 Nipro Corp Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
Table 59 Nipro Corp Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 NextPharma Company Information
Table 61 NextPharma Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
Table 62 NextPharma Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Lonza Company Information
Table 64 Lonza Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
Table 65 Lonza Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Jubilant Company Information
Table 67 Jubilant Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
Table 68 Jubilant Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Fareva Holding Company Information
Table 70 Fareva Holding Contract Pharmaceutical Manufacturing Product Portfolio, Specification and Application
Table 71 Fareva Holding Contract Pharmaceutical Manufacturing Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Contract Pharmaceutical Manufacturing Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Contract Pharmaceutical Manufacturing Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Contract Pharmaceutical Manufacturing Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Contract Pharmaceutical Manufacturing Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Contract Pharmaceutical Manufacturing Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Contract Pharmaceutical Manufacturing Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Contract Pharmaceutical Manufacturing Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Contract Pharmaceutical Manufacturing Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Contract Pharmaceutical Manufacturing Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Contract Pharmaceutical Manufacturing Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Contract Pharmaceutical Manufacturing Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Contract Pharmaceutical Manufacturing Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Contract Pharmaceutical Manufacturing Picture
Figure 2: Global Contract Pharmaceutical Manufacturing Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Contract Pharmaceutical Manufacturing Supply Chain Analysis
Figure 5: Contract Pharmaceutical Manufacturing Manufacturing Cost Structure Analysis
Figure 6: Product Picture of API
Figure 7: Product Picture of FDF
Figure 8: Global Contract Pharmaceutical Manufacturing Sales Market Share by Type, 2020
Figure 9: Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type, 2020
Figure 10: Contract Pharmaceutical Manufacturing in Specialty/Midsize
Figure 11: Global Contract Pharmaceutical Manufacturing Market: Specialty/Midsize 2016-2021
Figure 12: Contract Pharmaceutical Manufacturing in Generics
Figure 13: Global Contract Pharmaceutical Manufacturing Market: Generics 2016-2021
Figure 14: Global Contract Pharmaceutical Manufacturing Sales Market Share by Application, 2020
Figure 15: Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application, 2020
Figure 16: Global Contract Pharmaceutical Manufacturing Sales Market Share by Region 2016-2021
Figure 17: Global Contract Pharmaceutical Manufacturing Revenue Market Share by Region 2016-2021
Figure 18: North America Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 19: North America Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 20: Europe Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 21: Europe Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 24: South America Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 25: South America Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 28: North America Contract Pharmaceutical Manufacturing Sales Market Share by Country, 2020
Figure 29: North America Contract Pharmaceutical Manufacturing Revenue Market Share by Country, 2020
Figure 30: United States Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 31: United States Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 32: Canada Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 33: Canada Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 35: Mexico Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 36: Europe Contract Pharmaceutical Manufacturing Sales Market Share by Country, 2020
Figure 37: Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Country, 2020
Figure 38: Germany Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 39: Germany Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 40: France Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 41: France Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 42: UK Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 43: UK Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 44: Italy Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 45: Italy Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 46: Russia Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 46: Russia Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 47: Spain Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 48: Spain Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Contract Pharmaceutical Manufacturing Sales Market Share by Country, 2020
Figure 50: Asia Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Country, 2020
Figure 51: China Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 52: China Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 53: Japan Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 54: Japan Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 55: Korea Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 56: Korea Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 59: India Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 60: India Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 61: Australia Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 62: Australia Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 63: South America Contract Pharmaceutical Manufacturing Sales Market Share by Country, 2020
Figure 64: South America Contract Pharmaceutical Manufacturing Revenue Market Share by Country, 2020
Figure 65: Brazil Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 66: Brazil Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 68: Argentina Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 70: Colombia Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Contract Pharmaceutical Manufacturing Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Country, 2020
Figure 73: Turkey Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 74: Turkey Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Contract Pharmaceutical Manufacturing Sales (K Units) Status 2016-2021
Figure 78: South Africa Contract Pharmaceutical Manufacturing Revenue (Million USD) Status 2016-2021
Figure 79: Vetter Contract Pharmaceutical Manufacturing Revenue Market Share Globally (2019-2021)
Figure 80: Sopharma Contract Pharmaceutical Manufacturing Revenue Market Share Globally (2019-2021)
Figure 81: Recipharm Contract Pharmaceutical Manufacturing Revenue Market Share Globally (2019-2021)
Figure 82: Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue Market Share Globally (2019-2021)
Figure 83: Nipro Corp Contract Pharmaceutical Manufacturing Revenue Market Share Globally (2019-2021)
Figure 84: NextPharma Contract Pharmaceutical Manufacturing Revenue Market Share Globally (2019-2021)
Figure 85: Lonza Contract Pharmaceutical Manufacturing Revenue Market Share Globally (2019-2021)
Figure 86: Jubilant Contract Pharmaceutical Manufacturing Revenue Market Share Globally (2019-2021)
Figure 87: Fareva Holding Contract Pharmaceutical Manufacturing Revenue Market Share Globally (2019-2021)
Figure 88: Famar Contract Pharmaceutical Manufacturing Revenue Market Share Globally (2019-2021)
Figure 89: Global Contract Pharmaceutical Manufacturing Sales (K Units) Forecast (2022-2027)
Figure 90: Global Contract Pharmaceutical Manufacturing Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets